Julie Richardson - VEREIT Independent Director
Director
Ms. Julie G. Richardson is an Independent Director of the Company. From November 2012 until her retirement in October 2014, Ms. Richardson was a senior advisor to Providence Equity Partners LLC, a global asset management firm with over 40 billion in assets under management. From April 2003 to November 2012, she was a Partner and Managing Director at Providence Equity, and oversaw the firms New York office. While at Providence Equity, Ms. Richardsons responsibilities included leading the initiation and execution of deals, and optimizing operating results and strategic positioning of portfolio companies throughout Providence Equitys ownership period. Prior to Providence Equity, Ms. Richardson served as Global Head of JP Morgans Telecom, Media and Technology Group, and was previously a Managing Director in Merrill Lynch Co.s investment banking group. Ms. Richardson previously served on the Board of Directors of Arconic, Inc., a publicly traded manufacturer in the aerospace and automobile industries, from November 2016 to February 2018. Ms. Richardson has served on the Board of Directors of The Hartford Financial Services Group, Inc., an insurance and financial services company, since January 2014, and on the Board of Directors of UBS Group AG, a publicly traded financial services company, since May 2017. She has also served on the Board of Directors of Yext, Inc. since May 2015, a technology company that closed its initial public offering in 2017 since 2015.
| Age | 57 |
| Tenure | 9 years |
| Phone | 800 606-3610 |
| Web | www.ir.vereit.com |
Julie Richardson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Julie Richardson against VEREIT stock is an integral part of due diligence when investing in VEREIT. Julie Richardson insider activity provides valuable insight into whether VEREIT is net buyers or sellers over its current business cycle. Note, VEREIT insiders must abide by specific rules, including filing SEC forms every time they buy or sell VEREIT'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Julie Richardson over a month ago Acquisition by Julie Richardson of 10075 shares of Yext subject to Rule 16b-3 |
VEREIT Management Efficiency
The company has Return on Asset of 2.62 % which means that on every $100 spent on assets, it made $2.62 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 3.84 %, implying that it generated $3.84 on every 100 dollars invested. VEREIT's management efficiency ratios could be used to measure how well VEREIT manages its routine affairs as well as how well it operates its assets and liabilities.The company has 5.79 B in debt with debt to equity (D/E) ratio of 0.86, which is OK given its current industry classification. VEREIT Inc has a current ratio of 2.73, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist VEREIT until it has trouble settling it off, either with new capital or with free cash flow. So, VEREIT's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VEREIT Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VEREIT to invest in growth at high rates of return. When we think about VEREIT's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Howard Greene | Tandem Diabetes Care | 75 | |
| Franklin Miller | Merit Medical Systems | 76 | |
| Sarah Blumenstein | SEI Investments | 70 | |
| Carmen Romeo | SEI Investments | 73 | |
| Paul Buckman | Xtant Medical Holdings | 60 | |
| Rayford Wilkins | Morgan Stanley | 69 | |
| Jill Anderson | Merit Medical Systems | 58 | |
| Fred Cohen | Tandem Diabetes Care | 60 | |
| Richard Valencia | Tandem Diabetes Care | 56 | |
| Jon Wickwire | Xtant Medical Holdings | 70 | |
| Ann Millner | Merit Medical Systems | 65 | |
| Matthew Rizzo | Xtant Medical Holdings | N/A | |
| Jesse Treu | Tandem Diabetes Care | 67 | |
| Henry Anhalt | Tandem Diabetes Care | 54 | |
| David Goodman | Xtant Medical Holdings | 58 | |
| Nobuyuki Hirano | Morgan Stanley | 69 | |
| Michael Lopach | Xtant Medical Holdings | 65 | |
| Nolan Karras | Merit Medical Systems | 72 | |
| Thomas Gunderson | Merit Medical Systems | 66 | |
| Richard Edelman | Merit Medical Systems | 73 | |
| Robert Herz | Morgan Stanley | 67 | |
Management Performance
| Return On Equity | 3.84 | |||
| Return On Asset | 2.62 |
VEREIT Inc Leadership Team
Elected by the shareholders, the VEREIT's board of directors comprises two types of representatives: VEREIT inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VEREIT. The board's role is to monitor VEREIT's management team and ensure that shareholders' interests are well served. VEREIT's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VEREIT's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julie Richardson, Independent Director | ||
| Glenn Rufrano, Chief Executive Officer, Director | ||
| Mary Preusse, Independent Director | ||
| David Henry, Independent Director | ||
| Thomas Roberts, Chief Investment Officer, Executive Vice President | ||
| Hugh Frater, Independent Non-Executive Chairman of the Board | ||
| Michael Bartolotta, Chief Financial Officer, Executive Vice President | ||
| Gavin Brandon, Chief Accounting Officer and Sr. VP | ||
| Richard Lieb, Independent Director | ||
| Priscilla Almodovar, Independent Director | ||
| Susan Skerritt, Independent Director | ||
| Mark Ordan, Independent Director | ||
| Paul McDowell, Chief Operating Officer, Executive Vice President | ||
| William Miller, Executive Vice President - Investment Management; President and CEO of Cole Capital | ||
| Bruce Frank, Independent Director | ||
| Eugene Pinover, Independent Director | ||
| Lauren Goldberg, Executive Vice President General Counsel, Secretary |
VEREIT Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VEREIT a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.84 | |||
| Return On Asset | 2.62 | |||
| Profit Margin | 22.00 % | |||
| Operating Margin | 84.65 % | |||
| Current Valuation | 17.01 B | |||
| Shares Outstanding | 229.13 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 95.45 % | |||
| Number Of Shares Shorted | 9.9 M | |||
| Price To Earning | 57.96 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the VEREIT Inc information on this page should be used as a complementary analysis to other VEREIT's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in VEREIT Stock
If you are still planning to invest in VEREIT Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VEREIT's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |